<?xml version="1.0" encoding="UTF-8"?>
<p>While WHO continues to recommend a CD4 cell count before starting ART to inform the management of advanced disease and differentiated care in the Treat All era, it also recommends that CD4 testing be replaced by viral load measurement for monitoring of treatment and identification of treatment failure.
 <xref rid="R16" ref-type="bibr">16</xref>
 <xref ref-type="fig" rid="F2">Figure 2</xref> shows that in Southern and West Africa, the number of CD4 measurements tended to be stable over time, despite an increasing number of PLWHIV in care, while in East and Central Africa, the number of CD4 measurements dropped. At present, 53% of the active facilities reported routine CD4 testing and 62% routine viral load testing (
 <xref rid="T1" ref-type="table">table 1</xref>). The US Presidentâ€™s Emergency Plan for AIDS Relief, which provides substantial funding for AIDS treatment, care and prevention in countries most affected by the epidemic, has progressively reduced its support for CD4 testing.
 <xref rid="R17" ref-type="bibr">17</xref>
</p>
